Hydroxy acids and derivatives
Medchemexpress LLC Tylvalosin (tartrate) | 63428-13-7 | 96.0% | 50 MG
Tylvalosin tartrate is an orally active, broad-spectrum macrolide antibiotic and antiviral agent. It is useful in studying PRRSV infection, induces apoptosis, and possesses anti-inflammatory activity by relieving oxidative stress and alleviating acute lung injury through inhibiting NF-κB activation.
- Increases caspase-3 cleavage and promotes endocytosis in porcine neutrophils.
- Reduces stress and improves health in pigs during PRRSV vaccine immunization.
- Attenuates increase in white blood cells and reduction in CD8+ T cells after immunization.
- Relieves oxidative stress and alleviates acute lung injury by inhibiting NF-κB activation.
Medchemexpress LLC Morantel tartrate | 26155-31-7 | 99.0% | 1 ML
Morantel tartrate is an anthelmintic agent primarily used to control subclinical gastrointestinal parasitism in cattle. This compound can be detected in various biological fluids and feces for extended periods after administration, making it suitable for research applications. It is intended for research use only.
- Anthelmintic agent
- Controls subclinical gastrointestinal parasitism
- Can be detected in biological fluids and feces for over 98 days
- For research use only
- Purity of 99.01%
- Molecular weight of 370.42
- Off-white to light yellow solid appearance
Medchemexpress LLC 2-Hydroxybutyric acid | 600-15-7 | 98.0% | 104.10 | 1 ML
2-Hydroxybutyric acid (α-Hydroxybutyric acid) is an endogenous metabolite converted from 2-Aminobutyric acid, with 2-oxobutyric acid as an intermediate. It is recognized as a potential biomarker for type 2 diabetes and preeclampsia. It has also been shown to prevent acetaminophen (AP)-induced liver injury.
- Derived from 2-Aminobutyric acid.
- Potential biomarker for type 2 diabetes and preeclampsia.
- Prevents acetaminophen-induced liver injury.
- Synthesized as a co-product of insulin resistance.
- Enhances cell viabilities and reduces AP-induced cytotoxicities in studies.
- Administration in C57 mice prevented AP-induced liver injury and normalized gene expression.
Medchemexpress LLC Varenicline tartrate | 375815-87-5 | 100.0% | C17H19N3O6 | 1 ML
Varenicline tartrate is the tartrate salt of varenicline, a nicotinic acetylcholine receptor ligand used in research as a partial agonist of α4β2 nAChR. Supplied as a 10 mM solution in DMSO, this product is intended for laboratory research and analytical applications and is not for human use.
- Ready-to-use 10 mM solution in DMSO.
- High purity (99.96%) suitable for analytical applications.
- Small 1 mL vial minimizes freeze-thaw and waste.
- Validated for receptor pharmacology and in vitro assays.
- Stable when stored under recommended conditions.
Medchemexpress LLC L-Glyceric acid sodium | 146298-95-5 | 99.0% | 128.06 | 10 MG
L-Glyceric acid sodium is a urinary metabolite that accumulates in the rare inherited metabolic disease L-glyceric aciduria. It is used to diagnose primary hyperoxaluria type 2 (PH2) and to distinguish PH1 from PH2 based on its excretion.
- Urinary metabolite
- Used to diagnose primary hyperoxaluria type 2 (PH2)
- Helps distinguish PH1 from PH2
- For research use only
CC(O)=O | 100mg | 524649694](https://assets.fishersci.com/TFS-Assets/CCG/product-images/NC3962222.jpg-250.jpg)
eMolecules 6168-83-8 | (S)-3-Hydroxybutanoic acid | AA Blocks LLC | MFCD00137685 | 104.105 | C4H8O3 | 0.000 | C[C@H](O)CC(O)=O | 100mg | 524649694
(S)-3-Hydroxybutanoic acid | AA Blocks LLC | 6168-83-8 | MFCD00137685 | 104.105 | C4H8O3 | 0.000 | C[C@H](O)CC(O)=O | 100mg | 524649694
![Medchemexpress LLC 2-Propanol, 1-[4-(2-methoxyethyl)phenoxy]-3-[(1-methylethyl)amino]-, tartrate (2:1) | 56392-17-7 | 100.0% | 342.41 | 500 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000387190-logo.png-250.jpg){kind=logo}
Medchemexpress LLC 2-Propanol, 1-[4-(2-methoxyethyl)phenoxy]-3-[(1-methylethyl)amino]-, tartrate (2:1) | 56392-17-7 | 100.0% | 342.41 | 500 MG
Metoprolol tartrate is an orally active, selective β1-adrenoceptor antagonist, demonstrating anti-inflammation, antitumor, and anti-angiogenic properties. It is intended for research use only and not sold to patients.
- Purity: 99.98%
- Appearance: White to light yellow solid
- Storage: 4°C, sealed storage, away from moisture and light
- In solvent storage: -80°C for 6 months; -20°C for 1 month
Medchemexpress LLC 3-Hydroxybutyric acid sodium | 150-83-4 | 98.0% | 126.09 | 10MM/1ML
3-Hydroxybutyric acid sodium is a metabolite that is elevated in type I diabetes. It can modulate the properties of membrane lipids. It is also capable of interacting with lipids (modeled using a DPPC monolayer) and altering phase behavior at clinical concentrations, and diminishes the interfacial viscosity of DPPC Monolayers.
- Target: Endogenous Metabolite
- Research Areas: Metabolic Disease
- Classification of Application Fields: Ketones, Aldehydes, Acids
- Modulates membrane lipid properties
- Interacts with lipids and alters phase behavior
- Diminishes interfacial viscosity of DPPC Monolayers
![Medchemexpress LLC 2-Propanol, 1-[4-(2-methoxyethyl)phenoxy]-3-[(1-methylethyl)amino]-, (2R,3R)-2,3-dihydroxybutanedioate (2:1) | 56392-17-7 | 99.98% | 342.41 | 25MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000384117-logo.png-250.jpg){kind=logo}
Medchemexpress LLC 2-Propanol, 1-[4-(2-methoxyethyl)phenoxy]-3-[(1-methylethyl)amino]-, (2R,3R)-2,3-dihydroxybutanedioate (2:1) | 56392-17-7 | 99.98% | 342.41 | 25MG
Metoprolol tartrate is characterized as an orally active, selective β1-adrenoceptor antagonist. It has demonstrated various biological activities, including anti-inflammatory, antitumor, and anti-angiogenic properties. Studies have shown its ability to reduce proinflammatory cytokines and atherosclerosis, protect myocardial tissue from viral damage, decrease myocardial virus titers, and inhibit myocardial apoptosis.
- Orally active compound.
- Selective antagonist of a specific adrenoceptor.
- Exhibits anti-inflammatory effects.
- Demonstrates antitumor properties.
- Possesses anti-angiogenic activity.
- Reduces proinflammatory cytokines.
- Decreases atherosclerosis.
- Protects heart muscle from viral damage.
- Lowers myocardial virus titers.
- Inhibits programmed cell death in heart tissue.
Medchemexpress LLC 3-Hydroxybutyric acid-13C4 sodium | 287111-43-7 | 98.0% | 130.06 | 5 MG
3-Hydroxybutyric acid-13C4 sodium is the 13C labeled 3-Hydroxybutyric acid sodium. The unlabeled compound, 3-Hydroxybutyric acid sodium, is a metabolite elevated in type I diabetes and can modulate membrane lipid properties. This product is for research use only and is not sold to patients.
- Can be used as a tracer.
- Can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
- Appearance: Solid
- Color: White to off-white
- Shipping: Room temperature in continental US; may vary elsewhere.
- Storage: 4°C, sealed storage, away from moisture. In solvent: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture).
- Solubility in water: 25 mg/mL (192.22 mM); needs ultrasonic and warming.
Medchemexpress LLC Varenicline tartrate | 375815-87-5 | MFCD08460603 | 99.9% | 361.35 | C17H19N3O6 | 50 MG
Varenicline tartrate is the tartrate salt of varenicline, a nicotinic acetylcholine receptor partial agonist. Supplied as a high-purity research chemical for in vitro and analytical applications, it is intended for laboratory use only and not for human or clinical use.
- High purity (≈99.9%).
- CAS number 375815-87-5.
- Molecular weight 361.35 g/mol.
- Appearance: off-white to yellow solid.
- Available in multiple pack sizes, including small milligram quantities and larger bulk options.
- Recommended storage: sealed, away from moisture; in solvent: -80°C (6 months) or -20°C (1 month).
- Biological activity: partial agonist of α4β2 nicotinic acetylcholine receptors (IC50 ≈ 250 nM).
Medchemexpress LLC Morantel tartrate | 26155-31-7 | 99.0% | 100 MG
Morantel tartrate is an anthelmintic agent primarily used for the control of subclinical gastrointestinal parasitism in cattle on pasture. This broad-spectrum anthelmintic is effective and demonstrates low toxicity, with detectable presence in ruminal, abomasal, ileal fluids, and feces for over 98 days post-administration.
- Anthelmintic agent.
- Controls subclinical gastrointestinal parasitism.
- Broad spectrum effectiveness.
- Low toxicity.
- Extended detection in biological fluids and feces.
Aobchem Varenicline tartrate | 95% | CAS 375815-87-5 | 500mg
Varenicline tartrate | 95% | CAS 375815-87-5 | 500mg
